PROBLEM TO BE SOLVED: To provide an antibody-drug conjugate (ADC) and ADC derivatives for the treatment of CD70-expressing cancer and immunological disorders.SOLUTION: Anti-CD70 antibody combined with cytotoxic agent, immune suppressor or other therapeutic agents, and derivative of the same, and ...
An anti-CD70 antibody drug conjugate developed by Ambrx, Inc. has been administered to the first patient in a Phase I study in China. It marks the first ADC in active development that targets CD70.
#应用#客户文献解读|双抗+ADC组合拳:三阴性乳腺癌“新克星” #新品#Anti-Digoxin Antibody (26G10) (RGK23001)抗体 #动态#性激素|“不务正业”的跨界高手 产品详情 公司简介 公司评价 资质证书 手机查看 手机查看 一键电话致商家 抗体名: Anti-Mouse CD11b/ITGAM Antibody (M1/70)(流式抗体) 亚型: ...
PROBLEM TO BE SOLVED: To provide an antibody/drug conjugate (ADC) and ADC derivatives for the treatment of CD70 developing cancer and immunological disorders.SOLUTION: Cytotoxic agent, immune suppressor or anti-CD70 antibody combined with other therapeutic agents and derivative of the same, and a...
Using an expanded genetic code to create Engineered Precision Biologics (EPBs), Ambrx has developed ARX305, a CD70-targeted next-generation antibody drug conjugate (ADC) to potentially overcome the challenges associated with earlier ADCs and treat patients with cancers over-expressing CD70. ARX305 ...
According to the present invention, a method for treating a CD70-expressing cancer in a subject is provided, the method mediates ADC, ADCC, and CDC response or ADCP at least in the subject and the antigen-binding region that binds to CD70 the method comprising administering to the subject ...
An anti-CD70 antibody drug conjugate developed by Ambrx, Inc. has been administered to the first patient in a Phase I study in China. It marks the first ADC in active development that targets CD70.
According to the present invention, a method for treating a CD70-expressing cancer in a subject is provided, the method mediates ADC, ADCC, and CDC response or ADCP at least in the subject and the antigen-binding region that binds to CD70 the method comprising administering to the subject ...